GMP Standard Operating Procedure
Drafts inspection-ready GMP standard operating procedures for regulated manufacturing. Covers document control, role accountability, process controls, deviation/CAPA handling, and records management aligned to FDA CGMP (21 CFR 210/211), Part 11, ICH Q7/Q9/Q10, WHO GMP, PIC/S, and EU GMP. Use when creating or overhauling a GMP SOP, preparing for audits or inspections, or building compliance-ready procedures. Trigger: GMP, SOP, CGMP, 21 CFR 210, 21 CFR 211, Part 11, ICH Q7, ICH Q9, ICH Q10, WHO GMP, PIC/S, EU GMP.
GMP Standard Operating Procedure
Produces a GMP-compliant SOP that is inspection-ready and operationally executable.
Quick Start
- Gather inputs: process scope, applicable regulations, QMS context, equipment list, record systems.
- Walk through each SOP section below, filling tables and templates.
- Mark any unverified citations with
[VERIFY]. - Route for QA review and approval before release.
Prerequisites
Collect before drafting:
- Process scope — product type, dosage form, facility class, target markets
- Applicable regs — FDA CGMP, ICH, WHO, PIC/S, EU GMP, local requirements
- QMS context — document numbering, approval matrix, related SOPs
- Equipment — asset IDs, calibration/maintenance/qualification status
- Record systems — paper vs electronic, Part 11 status
- Inspection history — FDA 483s, warning letters, open CAPAs
- SME/approver list — production, QA, QC, engineering, management
SOP Sections
1. Document Control Page
| Field | Content |
|---|---|
| SOP Title | Precise scope (process/area) |
| SOP ID | Site numbering convention |
| Version | Numeric or semantic |
| Effective Date | Approved use date |
| Supersedes | Prior SOP ID/version |
| Prepared By | Name, role, date |
| Reviewed By | QA, SMEs |
| Approved By | QA/Management |
| Distribution | Controlled locations |
| Related SOPs | IDs and titles |
| Electronic Signatures | Part 11 status |
2. Purpose and Scope
Purpose:
This SOP establishes controlled steps for [process] to ensure GMP compliance under [reg citations].
Scope:
Applies to [areas, equipment, product types, personnel]. Excludes [exclusions with rationale].
Interfaces: [related SOP IDs].
3. Regulatory Basis
List only applicable regulations. Use [VERIFY] for unconfirmed citations.
| Authority | Citation |
|---|---|
| FDA CGMP | 21 CFR Parts 210/211 |
| Electronic records | 21 CFR Part 11 |
| ICH | Q7 (API), Q9, Q10 |
| WHO | TRS GMP guidance |
| PIC/S | GMP Guide |
| EU | EU GMP Guide + Annexes |
4. Definitions
Provide GMP-aligned definitions consistent with site QMS. Minimum set: CPP, CQA, deviation, OOS, OOT, batch record, validation, qualification, calibration.
5. Responsibilities Matrix
| Role | Duties | Decisions/Approvals | Records Owned |
|---|---|---|---|
| Production | Execute SOP steps | Stop work for deviations | Batch records |
| QA | Approve SOP, review deviations | Release/closure authority | QA review logs |
| QC | Testing, sampling | OOS disposition | Lab records |
| Engineering | Maintenance/calibration | Equipment readiness | PM/calibration logs |
| Management | Resource allocation | Final approval | Training matrix |
6. Materials, Equipment, and Utilities
| Item | ID/Spec | Qualification | Calibration/PM | Acceptance Criteria |
|---|---|---|---|---|
| Equipment | Asset ID | IQ/OQ/PQ status | Frequency | Tolerance |
| Materials | Grade/spec | Supplier status | Storage | COA required |
| Utilities | Water/HVAC/gases | Monitoring | Limits | Action levels |
7. Procedure Steps
Each step must specify role, action, records, and acceptance criteria.
| Step | Role | Action | CPP/CQA | Hold Point | Records |
|---|---|---|---|---|---|
| 1 | Production | [imperative action] | [range] | QA if required | [record] |
| 2 | QC | [sample/test] | [spec] | QA review | [record] |
| 3 | QA | [verification] | N/A | Release | [record] |
Step rules:
- Include decision points and stop-work criteria
- Define acceptance ranges for all CPPs/CQAs
- State required PPE/cleanroom behavior where applicable
- Require documentation at time of action (concurrent recording)
8. In-Process Controls
| Control | Frequency | Method | Acceptance | Action if OOR |
|---|---|---|---|---|
| [Control] | [per batch/time] | [method] | [spec] | [action] |
9. Deviations, OOS/OOT, and CAPA
- Document deviation within same shift or defined timeframe
- Quarantine affected material/lots
- Initiate root cause investigation
- Assess impact on product quality and patient safety
- Implement CAPA with effectiveness checks
- Document QA disposition and release decision
10. Documentation and Records
| Record | Owner | System | Review Timeline | Retention |
|---|---|---|---|---|
| Batch record | Production | Paper/eQMS | [timeframe] | Per 21 CFR 211.180 [VERIFY] |
| Calibration log | Engineering | Paper/eQMS | [timeframe] | [policy] |
| Training record | QA/HR | LMS/eQMS | [timeframe] | [policy] |
If electronic: require validation, audit trails, access control, e-signatures per Part 11.
11. Training and Qualification
- Initial training before first execution
- Retraining on each revision
- Qualification for roles with critical steps
- Document training effectiveness
12. Change Control and Revision History
| Version | Effective Date | Change Summary | Rationale | Approvers |
|---|---|---|---|---|
| 1.0 | [date] | Initial release | [reason] | [names] |
13. References
List all cited standards with version/date. Mark uncertain items [VERIFY].
14. Appendices
Include controlled templates: SOP execution checklist, batch record template, deviation report template, in-process control log, equipment cleaning log.
Pitfalls and Checks
- Language — use imperative, unambiguous phrasing; never advisory ("should consider")
- Citations — verify all regulatory citations are current; mark uncertain ones
[VERIFY] - Role segregation — maintain separation between production and QA/QC functions
- Retention — apply the strictest applicable retention requirement across jurisdictions
- Jurisdiction — add annexes for non-U.S. markets (EU, WHO, PIC/S requirements)
- Part 11 — confirm electronic record controls whenever eQMS or e-signatures are used
No additional documents ship with this skill.
Related Skills
Quality Agreement for Contract Manufacturing
Drafts Quality Agreements for pharmaceutical contract manufacturing. Assigns quality roles between product owners and CMOs under FDA cGMP (21 CFR 210…
Promotional Materials Review Policy
Drafts an internal Promotional Materials Review Policy for life sciences and pharmaceutical companies under FDA oversight. Covers promotional review …
Pharmaceutical Regulation Compliance Summary
Generates structured pharmaceutical regulatory compliance summaries covering FDA approval pathways, patent/IP intersections (Orange Book, Hatch-Waxma…
New Drug Application (NDA)
Drafts an eCTD-compliant New Drug Application (NDA) for FDA submission under 21 CFR Part 314. Compiles clinical trial data, CMC documentation, noncli…
Investigator Agreement
Drafts Investigator Agreements for FDA-regulated clinical trials between sponsors and principal investigators. Covers 21 CFR Parts 50, 56, 312/812, I…
Comments
Loading…